F.D.A. Disputes Finding That Avandia Is Safe
by
Lisa LaMendolaPosted
Fri 09 Jul 2010 12:00amAvandia should be withdrawn from the market — after millions of prescriptions , billions of dollars in sales and 11 years of wide use.
The panel’s decision will have broad... against its use, Avandia remains popular — with nearly two million prescriptions last year.
During that 2007 advisory meeting, the Record trial — specifically designed
Read on »
F.D.A. Panel Votes to Restrict Avandia/ NY Times
by
Meryl NassPosted
Wed 14 Jul 2010 8:01pm
why panel members would vote to restrict the drug's use, rather than taking it off the market, when Avandia does not appear to provide the benefits for which one treats diabetes...
Gardiner Harris @ the NY Times follows up on the FDA Avandia review
A federal medical advisory panel recommended Wednesday that Avandia , a controversial diabetes drug
Read on »
Avandia Raises Heart Risk But Should Stay on Market, FDA Panel Finds
by
HealthFinderPosted
Wed 14 Jul 2010 10:00am
on Avandia's future, 12 members voted for pulling the drug, 17 voted for new warning label revisions or restrictions on use, and three voted that no changes were needed.
"I don't think there's any question that the use of the drug will decrease and that both physicians and patients will look at the warning very carefully before prescribing AvandiaRead on »
Despite FDA Warning, AvandiaUse Varies Across U.S.
by
HealthFinderPosted
Wed 17 Nov 2010 12:00pm
WEDNESDAY, Nov. 17 (HealthDay News) -- Using the controversial diabetes drug Avandia as an example, new research finds that doctors' prescribing patterns vary across the country... in use before the warning -- around 15.5 percent use in Oklahoma versus about 8 percent in North Dakota," Shah said.
Right after the warning, the use of Avandia dropped
Read on »
Despite FDA Warning, AvandiaUse Varies Across U.S.
by
Medline PlusPosted
Wed 17 Nov 2010 5:00pm
WEDNESDAY, Nov. 17 (HealthDay News) -- Using the controversial diabetes drug Avandia as an example, new research finds that doctors' prescribing patterns vary across the country... in use before the warning -- around 15.5 percent use in Oklahoma versus about 8 percent in North Dakota," Shah said.
Right after the warning, the use of Avandia dropped
Read on »
For the RECORD, Avandia does not cause heart attacks.
by
Dr. Matthew M.Posted
Fri 05 Jun 2009 10:04pm
unnecessarily scared the socks of these folks!
Dr. David Nathan is another likely naysayer, given that his newest guidelines recommend that Avandia shouldn't be used.
From... of media hype.
I told you when the VADT trial came out that Avandia had been vindicated, and did not cause heart attacks.
I told you all about the flaws of the Nissen study
Read on »
Avandia Smackdown!!
by
Dr. Matthew M.Posted
Sun 04 Jul 2010 6:26am
that should have put the issue to rest showed absolutely no difference in cardiovascular issues with Avandia. In addition, patients who usedAvandia had improved diabetes control and less use of insulin. At the previous years ADA meeting, two other randomized studies (ACCORD and VADT), which both usedAvandia extensively also showed no issues related
Read on »
Avandia Vindicated!
by
Dr. Matthew M.Posted
Tue 24 Jun 2008 12:08pm
, with barely a mention. But the one headline from the good folks at MedPage today clearly caught my attention:VA Diabetes Trial Appears to Vindicate Rosiglitazone (Avandia) Safety... to this, let's review.
In May of 2007, Dr. Steve Nissenpublisheda meta-analysis of diabetes studies containing Avandia. This now famous (or infamous) study started the entire AvandiaRead on »
The Avandia Scare: Why it Matters, Who's Responsible, and What to Do
by
Dr. Matthew M.Posted
Tue 16 Jun 2009 8:15am
that not using TZD's like Avandia can double to triple the amount of patients needing insulin. Though the exact number from RECORD is not published, based on the what was presented...) as the preferred medications to use, leaving Actos as only a second line alternative, and taking Avandia and Januvia off the map. Though not all endocrinologists necessarily agree
Read on »